These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 37530187)

  • 1. [WHO classification of tumors of hematopoietic and lymphoid tissues, 2022 (5th edition): lymphoid tumors].
    Baram DV; Asaulenko ZP; Spiridonov IN; Krivolapov YA
    Arkh Patol; 2023; 85(4):24-31. PubMed ID: 37530187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues, 2022 (5th edition): Myeloid and Histiocytic Tumors].
    Asaulenko ZP; Spiridonov IN; Baram DV; Krivolapov YA
    Arkh Patol; 2023; 85(5):36-44. PubMed ID: 37814848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Revised WHO classification of tumors of hematopoietic and lymphoid tissues, 2017 (4th edition):lymphoid tumors].
    Polyatskin IL; Artemyeva AS; Krivolapov YA
    Arkh Patol; 2019; 81(3):59-65. PubMed ID: 31317932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction to the Fifth Edition of the World Health Organization Classification of Tumors of Hematopoietic and Lymphoid Tissues.
    Naresh KN; Medeiros LJ;
    Mod Pathol; 2023 Dec; 36(12):100330. PubMed ID: 37716508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fifth Edition of the World Health Organization Classification of Tumors of the Hematopoietic and Lymphoid Tissues: Mature T-Cell, NK-Cell, and Stroma-Derived Neoplasms of Lymphoid Tissues.
    Miranda RN; Amador C; Chan JKC; Guitart J; Rech KL; Medeiros LJ; Naresh KN;
    Mod Pathol; 2024 Aug; 37(8):100512. PubMed ID: 38734236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interpretation of lymphoid proliferations and lymphomas associated with immune deficiency and dysregulation in the 5th edition WHO classification of haematolymphoid tumours].
    Huang YH; Wang Z
    Zhonghua Bing Li Xue Za Zhi; 2024 Jul; 53(7):651-654. PubMed ID: 38955693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interpretation of histiocytic/dendritic cell neoplasms and stromal-derived neoplasms of lymphoid tissues in the 5th edition of WHO classification of haematolymphoid tumors].
    Yin WH; Li XQ
    Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):12-15. PubMed ID: 38178740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interpretation of T-cell and NK-cell lymphoid proliferations and lymphomas in the 5th edition of the WHO classification of haematolymphoid tumours].
    Zhao S; Li GD; Liu WP
    Zhonghua Bing Li Xue Za Zhi; 2024 Jun; 53(6):535-540. PubMed ID: 38825896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fifth Edition of the World Health Classification of Tumors of the Hematopoietic and Lymphoid Tissues: B-cell Neoplasms.
    Medeiros LJ; Chadburn A; Natkunam Y; Naresh KN;
    Mod Pathol; 2024 Apr; 37(4):100441. PubMed ID: 38309432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Introduction to a review series: the 2016 revision of the WHO classification of tumors of hematopoietic and lymphoid tissues.
    Cazzola M
    Blood; 2016 May; 127(20):2361-4. PubMed ID: 27069255
    [No Abstract]   [Full Text] [Related]  

  • 11. Updates in the Pathology of Precursor Lymphoid Neoplasms in the Revised Fourth Edition of the WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues.
    Wenzinger C; Williams E; Gru AA
    Curr Hematol Malig Rep; 2018 Aug; 13(4):275-288. PubMed ID: 29951888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 5th edition of the World Health Organization Classification of mature lymphoid and stromal tumors - an overview and update.
    Attygalle AD; Chan JKC; Coupland SE; Du MQ; Ferry JA; Jong D; Gratzinger D; Lim MS; Naresh KN; Nicolae A; Ott G; Rosenwald A; Schuh A; Siebert R
    Leuk Lymphoma; 2024 Apr; 65(4):413-429. PubMed ID: 38189838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is new in the 5th edition of the World Health Organization classification of mature B and T/NK cell tumors and stromal neoplasms?
    Attygalle AD; Chan JKC; Coupland SE; Du MQ; Ferry JA; de Jong D; Gratzinger D; Lim MS; Nicolae A; Ott G; Rosenwald A; Schuh A; Siebert R;
    J Hematop; 2024 Jun; 17(2):71-89. PubMed ID: 38683440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous T-cell lymphomas in the revised 4th edition of World Health Organization classification of tumors of hematopoietic and lymphoid tissues (2017).
    Xavier Júnior JCC; Ocanha-Xavier JP
    An Bras Dermatol; 2018; 93(6):871-873. PubMed ID: 30484532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms.
    Vardiman JW
    Chem Biol Interact; 2010 Mar; 184(1-2):16-20. PubMed ID: 19857474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Hematolymphoid Proliferations and Neoplasia.
    Ferry JA
    Head Neck Pathol; 2022 Mar; 16(1):101-109. PubMed ID: 35312979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Overview of lymphoid neoplasms in the fourth edition of the WHO classification].
    Tohda S
    Rinsho Byori; 2012 Jun; 60(6):560-4. PubMed ID: 22880234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of the International Consensus and 5th World Health Organization classifications of mature B-cell lymphomas.
    Falini B; Martino G; Lazzi S
    Leukemia; 2023 Jan; 37(1):18-34. PubMed ID: 36460764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The World Health Organization classification of malignant lymphoma: incidence and clinical prognosis in HTLV-1-endemic area of Fukuoka.
    Ohshima K; Suzumiya J; Kikuchi M
    Pathol Int; 2002 Jan; 52(1):1-12. PubMed ID: 11940200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding the New WHO Classification of Lymphoid Malignancies: Why It's Important and How It Will Affect Practice.
    Jaffe ES; Barr PM; Smith SM
    Am Soc Clin Oncol Educ Book; 2017; 37():535-546. PubMed ID: 28561690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.